home > drugs a-z list > tarceva (erlotinib) drug center

Recommended Topic Related To:

Tarceva

Pancreatic cancer facts

  • Most pancreatic cancers are adenocarcinomas.
  • Few patients diagnosed with pancreatic cancer have identifiable risk factors.
  • Pancreatic cancer is highly lethal.
  • Pancreatic cancer is difficult to diagnose, and the diagnosis is often made late in the disease course. Symptoms include weight loss, back pain, and jaundice.
  • The only curable treatment is surgical removal of all cancer.
  • Chemotherapy after surgery can lower the chances of the cancer returning.
  • Chemotherapy for metastatic pancreatic cancer can extend life and improve the quality of life for people with the disease.
  • Patients diagnosed with pancreatic cancer are encouraged to seek out clinical trials to improve pancreatic cancer treatment.
  • Many organizations exist to help provide information and support for patients and families fighting pancreatic cancer.

Wh...

Tarceva

font size

Tarceva Drug Center

Medical Editor: John P. Cunha, DO, FACOEP

Tarceva (erlotinib) is used in the treatment of non-small cell lung cancer (NSCLC) or pancreatic cancer. It is a cancer chemotherapy medication. Common side effects include nausea, vomiting, loss of appetite, mouth sores, dry skin, or eye irritation.

The recommended daily dose of Tarceva for NSCLC is 150 mg taken on an empty stomach at least one hour before or two hours after the ingestion of food. The recommended daily dose of Tarceva for pancreatic cancer is 100 mg taken on an empty stomach at least one hour before or two hours after the ingestion of food, in combination with gemcitabine. For both conditions, treatment should continue until disease progression or unacceptable toxicity occurs. Tarceva may interact with HIV/AIDS medications, rifamycins, clarithromycin, nefazodone, telithromycin, troleandomycin, carbamazepine, phenobarbital, phenytoin, antifungal medications, or St. John's Wort. Tell your doctor all medications you are taking. Tarceva is not recommended for use during pregnancy. It may cause harm to a fetus or a miscarriage. Women of childbearing age should use reliable form(s) of birth control during treatment and for at least 2 weeks following the end of treatment with this drug. It is not known whether this drug passes into breast milk. Breast-feeding while using this drug is not recommended.

Our Tarceva (erlotinib) Drug Center provides a comprehensive view of available drug information as well as related drugs, user reviews, supplements, and diseases and conditions articles.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Tarceva Prescribing Information: Indications & Dosage

TARCEVA® (erlotinib) Structural Formula Illustration

Non-Small Cell Lung Cancer (NSCLC)

TARCEVA (erlotinib) monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy [see Clinical Studies].

TARCEVA (erlotinib) monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen [see Clinical Studies].

Results from two, ...

Read the complete drug monograph for Tarceva »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Tarceva Patient Information: Side Effects

If you experience any of the following serious side effects from erlotinib, contact your doctor immediately:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
  • lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
  • severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
  • eye pain or irritation.

Other, less serious side effects may be more likely to occur. Continue taking erlotinib and ta...

Read the complete patient information for Tarceva »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Tarceva Consumer Information: Uses

This medication is used to treat lung cancer. Erlotinib is used after other chemotherapy drugs have not been effective. It works by slowing cancer cell growth.

HOW TO USE: Take this medication by mouth on an empty stomach, at least 1 hour before or 2 hours after a meal, usually once daily, or as directed by your doctor. Do not take erlotinib within 2 hours of taking an antacid (liquid or tablets). Doing so can prevent the absorption of the medication.

Acid-lowering medications for indigestion, heartburn, or ulcers (such as prescription or over-th...

Read the complete consumer information for Tarceva »

What is Tarceva Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Tarceva - User Reviews

Tarceva User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Tarceva sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.